Parapneumonic pleural effusion and empyema

Respiration

Volumn 75, Issue 3, 2008, Pages 241-250

  Koegelenberg, Coenraad F N ^a   Diaconi, Andreas H ^a   Bolligeri, Chris T ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Empyema; Fibrinolytics; Parapneumonic pleural effusion; Thoracoscopy; Thoracostomy; Thoracotomy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; FIBRINOLYTIC AGENT; LINEZOLID; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VANCOMYCIN;

ANTIBIOTIC THERAPY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EMPYEMA; MONOTHERAPY; PATHOGENESIS; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THORACOCENTESIS; THORACOSCOPY; THORAX DRAINAGE; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; CHEST TUBES; DIAGNOSTIC IMAGING; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL EFFUSION; PNEUMONIA; PUNCTURES; RISK FACTORS; STREPTOKINASE; THORACOSCOPY; THORACOSTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 41349103862     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117172     Document Type: Review

References (60)

1. Light RW: Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80.
2. Chapman SJ, Davies RJ: Recent advances in parapneumonic effusions and empyema. Curr Opin Pulm Med 2004;10:299-304.
3. Sahn SA: Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148:813-817.
4. Ferguson AD, Prescott RJ, Selkon JB, et al: The clinical course and management of thoracic empyema. Q J Med 1996;89:285-289.
5. Alfageme I, Munoz F, Pena N, Umbria S: Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest 1993;103:839-843.
6. Golpe R, Marin B, Alonso M: Lemierre's syndrome (necrobacillosis). Postgrad Med J 1999;75:141-144.
7. Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP: Miliary tuberculosis as a cause of acute empyema. Respiration 2003;70:529-532.
8. Andrews NC, Parker EF, Shaw RR, Wilson NJ, Webb WR: Management of nontuberculous empyema. Am Rev Respir Dis 1962;85:935-936.
9. Jantz MA, Antony VB: Pathophysiology of the pleura. Respiration 2008;75:121-133.
10. Light RW, Girard WM, Jenkins SG, George RB: Parapneumonic effusions. Am J Med 1980;69:507-512.
11. Pine JR, Hollman JL: Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 1983;84:109-111.
12. Idell S, Girard W, Koenig KB, et al: Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991;144:187-194.
13. Aleman C, Alegre J, Monasterio J, et al: Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 2003;105:601-607.
14. Sasse SA, Jadus MR, Kukes GD: Pleural fluid transforming growth factor-β1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 2003;168:700-705.
15. Maskell NA, Davies CW, Nunn AJ, et al: U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874.
16. Maskell NA, Davies CW, Jones E, Davies RJO: The characteristics of 300 patients participating in the MRC/BTS multicenter intra-pleural streptokinase vs. placebo trial (ISRCTN-39138989). American Thoracic Society Meeting, Atlanta, 2002.
17. Light RW, Girard WM, Jenkinson SG, George RB: Parapneumonic effusions. Am J Med 1980;69:507-512.
18. Tsai TH, Yang PC: Ultrasound in the diagnosis and management of pleural disease. Curr Opin Pulm Med 2003;9:282-290.
19. Diacon AH, Theron J, Bolliger CT: Transthoracic ultrasound for the pulmonologist. Curr Opin Pulm Med 2005;11:307-312.
20. Chen KY, Liaw YS, Wang HC, et al: Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med 2000;19:837-843.
21. Tu CY, Hsu WH, Hsia TC, et al: Pleural effusions in febrile medical ICU patients: chest ultrasound study. Chest 2004;126:1274-1280.
22. Marks WM, Filly RA, Callen PW: Real-time evaluation of pleural lesions: new observations regarding the probability of obtaining free fluid. Radiology 1982;142:163-164.
23. Simmers TA, Jie C, Sie B: Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg 1999;47:77-81.
24. Diacon AH, Brutsche MH, Soler M: Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003;123:436-441.
25. Froudarakis ME: Diagnostic work-up of pleural effusions. Respiration 2008;75:4-13.
26. Aquino SL, Webb WR, Gushiken BJ: Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994;192:803-808.
27. Colice GL, Curtis A, Deslauriers J, et al: Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-1171.
28. Kalomenidis I, Bouros D: Pleural fluid pH in parapneumonic pleural effusions: drawing the line. Respiration 2005;72:345-346.
29. Diacon AH, Van de Wal BW, Wyser C, et al: Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003;22:589-591.
30. Jimenez Castro D, Diaz Nuevo G, Perez-Rodriguez E, Light RW: Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003;21:220-224.
31. Davies CW, Gleeson FV, Davies RJ, BTS Pleural Disease Group, a sub-group of the BTS Standards of Care Committee: BTS guidelines for the management of pleural infection. Thorax 2003;58(suppl II):ii18-ii28.
32. Hughes CE, Van Scoy RE: Antibiotic therapy of pleural empyema. Semin Respir Infect 1991;6:94-102.
33. Shankar S, Gulati M, Kang M, Gupta S, Suri S: Image-guided percutaneous drainage of thoracic empyema: can sonography predict the outcome? Eur Radiol 2000;10:495-499.
34. Ali I, Unruh H: Management of empyema thoracis. Ann Thorac Surg 1990;50:355-359.
35. Ashbaugh DG: Empyema thoracis: factors influencing morbidity and mortality. Chest 1991;99:1162-1165.
36. Keeling AN, Leong S, Logan PM, Lee MJ: Empyema and effusion: outcome of image-guided small-bore catheter drainage. Cardiovasc Intervent Radiol 2008;31:135-141.
37. Tillett WS, Sherry S: The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 1949;28:173-190.
38. Davies RJ, Traill ZC, Gleeson FV: Randomised controlled trial of intrapleural streptokinase in community acquired pleural infections. Thorax 1997;52:416-421.
39. Bouros D, Schiza S, Tzanakis N, et al: Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J 1996;9:1656-1659.
40. Bouros D, Schiza S, Patsourakis G, et al: Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-295.
41. Bouros D, Schiza S, Tzanakis N, et al: Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42.
42. Lim TK, Chin NK: Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 1999;13:514-518.
43. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al: Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001;55:658-660.
44. Diacon AH, Theron J, Schuurmans MM, et al: Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49-53.
45. Heffner JE: Multicenter trials of treatment for empyema - after all these years. N Engl J Med 2005;352:926-928.
46. Diacon AH, Koegelenberg CF, Bolliger CT: A trial of intrapleural streptokinase. N Engl J Med 2005;352:2243-2245.
47. Bouros D, Antoniou KM, Light RW: Intrapleural streptokinase for pleural infection. BMJ 2006;332:133-134.
48. Misthos P, Sepsas E, Konstantinou M, et al: Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg 2005;28:599-603.
49. Tokuda Y, Matsushima D, Stein GH, Miyagi S: Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest 2006;129:783-790.
50. Light RW, Nguyen T, Mulligan ME, Sasse SA: The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying of thick purulent exudative material from loculated empyema. Lung 2000;178:13-18.
51. Cassina PC, Hauser M, Hillejan L, et al: Video-assisted thoracoscopy in the treatment of pleural empyema: Stage-based management and outcome. J Thorac Cardiovasc Surg 1999;117:234-238.
52. Silen ML, Naunheim KS: Thoracoscopic approach to the management of empyema thoracis: indications and results. Chest Surg Clin N Am 1996;6:491-499.
53. Wait MA, Sharma S, Hohn J, Dal Nogare A: A randomized trial of empyema therapy. Chest 1997;111:1548-1551.
54. Pothula V, Krellenstein DJ: Early aggressive surgical management of parapneumonic empyemas. Chest 1994;105:832-836.
55. Sonnapa S, Cohen G, Owens CM, et al: Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006;174:221-227.
56. Mandal AK, Thadepalli H, Mandal AK, et al: Outcome of primary empyema thoracis: therapeutic and microbiological aspects. Ann Thorac Surg 1998;66:1782-1786.
57. Deslauriers J, Jacques LF, Gregoire J: Role of Eloesser flap and thoracoplasty in the third millennium. Chest Surg Clin N Am 2002;12:605-623.
58. Thurer RJ: Decortication in thoracic empyema: indications and surgical technique. Chest Surg Clin N Am 1996;6:461-490.
59. Pothula V, Krellenstein DJ: Early aggressive surgical management of parapneumonic empyemas. Chest 1994;105:832-836.
60. Neff CC, van Sonnenberg E, Lawson DW, Patton AS: CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology 1990;176:195-197.